Spyre Therapeutics Inc (NAS:SYRE)
$ 35.92 0.79 (2.25%) Market Cap: 1.83 Bil Enterprise Value: 1.63 Bil PE Ratio: 0 PB Ratio: 8.35 GF Score: 51/100

Spyre Therapeutics Inc (SYRE) Transcripts

  • 1